Publications by authors named "Scott Guenthner"

Claim this Profile
R
Roflumilast foam 0.3% for adolescent and adult patients with seborrheic dermatitis: A randomized, double-blinded, vehicle-controlled, phase 3 trial.
Andrew Blauvelt, Zoe D Draelos, Linda Stein Gold, Javier Alonso-Llamazares, Neal Bhatia, Scott T Guenthner

J Am Acad Dermatol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics and outcomes for participants with congenital ichthyosis who responded to treatment with the topical isotretinoin formulation TMB-001: results from the Phase IIb CONTROL study.
Christopher G Bunick, Joyce M C Teng, Scott Guenthner, Kalyani Marathe, Steven Kempers

Clin Exp Dermatol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase IIb randomized CONTROL study demonstrates a novel topical isotretinoin formulation, TMB-001, is safe and effective in participants with either recessive X-linked or autosomal recessive lamellar congenital ichthyosis.
Dedee F Murrell, Joyce M C Teng, Scott Guenthner, Kalyani Marathe, Steven Kempers

Clin Exp Dermatol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Roflumilast Foam, 0.3%, in Patients With Seborrheic Dermatitis: A Double-blind, Vehicle-Controlled Phase 2a Randomized Clinical Trial.
Matthew J Zirwas, Zoe D Draelos, Janet DuBois, Leon H Kircik, Angela Y Moore, Scott T Guenthner

JAMA Dermatol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Topical Isotretinoin (TMB-001) Treatment for 12 Weeks Did Not Result in Clinically Relevant Laboratory Abnormalities in Participants with Congenital Ichthyosis in the Phase 2b CONTROL Study.
Kalyani Marathe, Joyce M C Teng, Scott Guenthner, Christopher G Bunick, Steven Kempers

Dermatol Ther (Heidelb)· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Safety and Efficacy of Roflumilast Cream 0.15% and 0.05% in Patients With Atopic Dermatitis: Randomized, Double-Blind, Phase 2 Proof of Concept Study.
Melinda Gooderham, Leon Kircik, Matthew Zirwas, Mark Lee, Steven Kempers, Scott Guenthner

J Drugs Dermatol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The CONTROL study: A randomized, double-blind vehicle-controlled phase 2b study of novel topical isotretinoin formulation demonstrates improvement in recessive X-linked and autosomal recessive lamellar congenital ichthyosis.
Joyce M C Teng, Christopher G Bunick, Scott Guenthner, Dedee F Murrell, Kalyani Marathe

J Am Acad Dermatol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world assessment and treatment of locally advanced basal cell carcinoma: Findings from the RegiSONIC disease registry.
Aleksandar Sekulic, Simon Yoo, Ragini Kudchadkar, Julie Guillen, Gary Rogers, Scott Guenthner

PLoS One· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 3 Trials of Tapinarof Cream for Plaque Psoriasis.
Mark G Lebwohl, Linda Stein Gold, Bruce Strober, Kim A Papp, April W Armstrong, Scott Guenthner

N Engl J Med· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II, Double-Blind, Vehicle-Controlled Study to Determine the Cantharidin Dose Regimen, Efficacy, Safety, and Tolerability of VP-102 in Subjects with External Genital Warts.
Scott Guenthner, Wendy McFalda, Melita Tate, Kimberly Eads, Jayson Rieger

Am J Clin Dermatol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVE-1: A Phase 2, Open-Label Study to Evaluate Efficacy and Safety and the Optimal Regimen of VP-102, a Proprietary Drug-Device Product Containing Topical Cantharidin (0.7% w/v) Under Occlusion for the Treatment of Common Warts.
Scott Guenthner, Wendy McFalda, Pearl Kwong, Kimberly Eads, Morgan McCafferty

Dermatol Ther (Heidelb)· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inter- and Intra-physician variation in quantifying actinic keratosis skin photodamage.
Benjamin Schmeusser, Christina Borchers, Jeffrey B Travers, Samia Borchers, Julian Trevino, Scott Guenthner

J Clin Investig Dermatol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Halobetasol Propionate Lotion 0.01% for Moderate-to-Severe Plaque Psoriasis: Pooled Analysis in Male and Female Participants.
Fran E Cook-Bolden, Adelaide A Hebert, Scott T Guenthner, Robert Kang, Gina Martin

J Drugs Dermatol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, Safety, and Patient-Reported Outcomes in Patients with Moderate-to-Severe Plaque Psoriasis Treated with Brodalumab for 5 Years in a Long-Term, Open-Label, Phase II Study.
Mark G Lebwohl, Andrew Blauvelt, Alan Menter, Kim A Papp, Scott Guenthner

Am J Clin Dermatol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantifying skin photodamage with spatial frequency domain imaging: statistical results.
Jeffrey B Travers, Chien Poon, Trevor Bihl, Benjamin Rinehart, Christina Borchers, Scott Guenthner

Biomed Opt Express· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Once-Daily Oral Sarecycline 1.5 mg/kg/day Is Effective for Moderate to Severe Acne Vulgaris: Results from Two Identically Designed, Phase 3, Randomized, Double-Blind Clinical Trials.
Angela Moore, Lawrence J Green, Suzanne Bruce, Neil Sadick, Eduardo Tschen, Scott Guenthner

J Drugs Dermatol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two Multicenter, Randomized, Double-Blind, Parallel Group Comparison Studies of a Novel Enhanced Lotion Formulation of Halobetasol Propionate, 0.05% Versus Its Vehicle in Adult Subjects With Plaque Psoriasis.
David Pariser, Michael Bukhalo, Scott Guenthner, Steven Kempers, Stephen Shideler

J Drugs Dermatol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health care resource use, productivity, and costs among patients with moderate to severe plaque psoriasis in the United States.
Caroline P Schaefer, Joseph C Cappelleri, Rebecca Cheng, Jason C Cole, Scott Guenthner

J Am Acad Dermatol· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A skin cancer education initiative at a professional baseball game and results of a skin cancer survey.
Emily Ann Jungers, Scott Thomas Guenthner, Evan R Farmer, Susan M Perkins

Int J Dermatol· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis